The State of Israel has become known globally as a technological powerhouse, whether in the fields of agriculture, medicine, cybertechnology or finance – now, a new treatment containing cannabidiol (CBD) could be the Jewish state’s next major technological breakthrough.
Innocan Pharma Corporation (Pink: INNPF; CSE: INNO; FSE: IP4) is a Canadian- Israeli focusing on the development of pharmaceuticals which utilize cannabidiol (CBD) with other chemical elements in order to create medical solutions and bring these products into the treatment market.
Innocan is generally dealing in the development of multiple drug delivery programs which encompass CBD. Their partnership with Ramot at Tel Aviv University has produced cutting edge technology which uses CBD to penetrate the central nervous system (CNS) and potentially the Coronavirus (COVID-19).
This week, Innocan announced that they will move onto the second …